In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MicroPort Medical (Shanghai) Acquires Beijing Pangerui Medical Equipment

This article was originally published in PharmAsia News

Executive Summary

MicroPort Medical (Shanghai) announced it acquired Beijing Pangerui Medical Equipment, its first such foray. MicroPort sells mainly cardiac and cerebrovascular products, with its drug-eluting stents accounting for around 30 percent of China's market. Pangerui is a private high-tech firm that offers Shengtang insulin pump as its key product. MicroPort believes the acquisition can enrich its product lines and make it a more comprehensive medical devices company. However, industry analysts note that the company is expanding its performance in preparation for a listing in the U.S., which is expected to raise up to $150 million. (Click here for more - Chinese Language)



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts